197 related articles for article (PubMed ID: 26305332)
1. Interleukin 21 Controls mRNA and MicroRNA Expression in CD40-Activated Chronic Lymphocytic Leukemia Cells.
De Cecco L; Capaia M; Zupo S; Cutrona G; Matis S; Brizzolara A; Orengo AM; Croce M; Marchesi E; Ferrarini M; Canevari S; Ferrini S
PLoS One; 2015; 10(8):e0134706. PubMed ID: 26305332
[TBL] [Abstract][Full Text] [Related]
2. Resistance to CD95-mediated apoptosis of CD40-activated chronic lymphocytic leukemia B cells is not related to lack of DISC molecules expression.
de Totero D; Montera M; Rosso O; Clavio M; Balleari E; Foa R; Gobbi M
Hematol J; 2004; 5(2):152-60. PubMed ID: 15048066
[TBL] [Abstract][Full Text] [Related]
3. Lenalidomide Induces Interleukin-21 Production by T Cells and Enhances IL21-Mediated Cytotoxicity in Chronic Lymphocytic Leukemia B Cells.
Browning RL; Byrd WH; Gupta N; Jones J; Mo X; Hertlein E; Yu L; Muthusamy N; Byrd JC
Cancer Immunol Res; 2016 Aug; 4(8):698-707. PubMed ID: 27287425
[TBL] [Abstract][Full Text] [Related]
4. Biological analysis of chronic lymphocytic leukemia: integration of mRNA and microRNA expression profiles.
Dong L; Bi KH; Huang N; Chen CY
Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909901
[TBL] [Abstract][Full Text] [Related]
5. CLL cells respond to B-Cell receptor stimulation with a microRNA/mRNA signature associated with MYC activation and cell cycle progression.
Pede V; Rombout A; Vermeire J; Naessens E; Mestdagh P; Robberecht N; Vanderstraeten H; Van Roy N; Vandesompele J; Speleman F; Philippé J; Verhasselt B
PLoS One; 2013; 8(4):e60275. PubMed ID: 23560086
[TBL] [Abstract][Full Text] [Related]
6. IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia.
Ruiz-Lafuente N; Alcaraz-García MJ; Sebastián-Ruiz S; García-Serna AM; Gómez-Espuch J; Moraleda JM; Minguela A; García-Alonso AM; Parrado A
PLoS One; 2015; 10(4):e0124936. PubMed ID: 25909590
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells.
Li S; Moffett HF; Lu J; Werner L; Zhang H; Ritz J; Neuberg D; Wucherpfennig KW; Brown JR; Novina CD
PLoS One; 2011 Mar; 6(3):e16956. PubMed ID: 21408091
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of B-cell proliferation by IL21 in different subsets of chronic lymphocytic leukemia.
Ghalamfarsa G; Jadidi-Niaragh F; Hojjat-Farsangi M; Asgarian-Omran H; Yousefi M; Tahmasebi F; Khoshnoodi J; Razavi SM; Saboor-Yaraghi AA; Rabbani H; Jeddi-Tehrani M; Shokri F
Cytokine; 2013 Jun; 62(3):439-45. PubMed ID: 23579027
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia.
Ahearne MJ; Willimott S; Piñon L; Kennedy DB; Miall F; Dyer MJ; Wagner SD
Br J Haematol; 2013 Aug; 162(3):360-70. PubMed ID: 23710828
[TBL] [Abstract][Full Text] [Related]
10. Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212.
Tavolaro S; Colombo T; Chiaretti S; Peragine N; Fulci V; Ricciardi MR; Messina M; Bonina S; Brugnoletti F; Marinelli M; Di Maio V; Mauro FR; Del Giudice I; Macino G; Foà R; Guarini A
Genes Chromosomes Cancer; 2015 Apr; 54(4):222-34. PubMed ID: 25645730
[TBL] [Abstract][Full Text] [Related]
11. B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL.
Ferrer G; Bosch R; Hodgson K; Tejero R; Roué G; Colomer D; Montserrat E; Moreno C
Br J Haematol; 2014 Feb; 164(4):570-8. PubMed ID: 24245956
[TBL] [Abstract][Full Text] [Related]
12. miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors.
Sharma S; Pavlasova GM; Seda V; Cerna KA; Vojackova E; Filip D; Ondrisova L; Sandova V; Kostalova L; Zeni PF; Borsky M; Oppelt J; Liskova K; Kren L; Janikova A; Pospisilova S; Fernandes SM; Shehata M; Rassenti LZ; Jaeger U; Doubek M; Davids MS; Brown JR; Mayer J; Kipps TJ; Mraz M
Blood; 2021 May; 137(18):2481-2494. PubMed ID: 33171493
[TBL] [Abstract][Full Text] [Related]
13. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.
Ghia P; Strola G; Granziero L; Geuna M; Guida G; Sallusto F; Ruffing N; Montagna L; Piccoli P; Chilosi M; Caligaris-Cappio F
Eur J Immunol; 2002 May; 32(5):1403-13. PubMed ID: 11981828
[TBL] [Abstract][Full Text] [Related]
14. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
Zhu DX; Zhu W; Fang C; Fan L; Zou ZJ; Wang YH; Liu P; Hong M; Miao KR; Liu P; Xu W; Li JY
Carcinogenesis; 2012 Jul; 33(7):1294-301. PubMed ID: 22610076
[TBL] [Abstract][Full Text] [Related]
15. B-CLL cells acquire APC- and CTL-like phenotypic characteristics after stimulation with CpG ODN and IL-21.
Hagn M; Blackwell SE; Beyer T; Ebel V; Fabricius D; Lindner S; Stilgenbauer S; Simmet T; Tam C; Neeson P; Trapani JA; Schrezenmeier H; Weiner GJ; Jahrsdörfer B
Int Immunol; 2014 Jul; 26(7):383-95. PubMed ID: 24497611
[TBL] [Abstract][Full Text] [Related]
16. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
17. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
Yang YQ; Tian T; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Wang L; Fan L; Li JY; Xu W
BMC Cancer; 2018 Oct; 18(1):1009. PubMed ID: 30348117
[TBL] [Abstract][Full Text] [Related]
18. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
[TBL] [Abstract][Full Text] [Related]
19. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis.
Marton S; Garcia MR; Robello C; Persson H; Trajtenberg F; Pritsch O; Rovira C; Naya H; Dighiero G; Cayota A
Leukemia; 2008 Feb; 22(2):330-8. PubMed ID: 17989717
[TBL] [Abstract][Full Text] [Related]
20. Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering.
Tromp JM; Tonino SH; Elias JA; Jaspers A; Luijks DM; Kater AP; van Lier RA; van Oers MH; Eldering E
Oncogene; 2010 Sep; 29(36):5071-82. PubMed ID: 20581863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
